1. Home
  2. AFYA vs ARQT Comparison

AFYA vs ARQT Comparison

Compare AFYA & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AFYA
  • ARQT
  • Stock Information
  • Founded
  • AFYA 1999
  • ARQT 2016
  • Country
  • AFYA Brazil
  • ARQT United States
  • Employees
  • AFYA N/A
  • ARQT N/A
  • Industry
  • AFYA Other Consumer Services
  • ARQT Biotechnology: Pharmaceutical Preparations
  • Sector
  • AFYA Real Estate
  • ARQT Health Care
  • Exchange
  • AFYA Nasdaq
  • ARQT Nasdaq
  • Market Cap
  • AFYA 1.6B
  • ARQT 1.7B
  • IPO Year
  • AFYA 2019
  • ARQT 2020
  • Fundamental
  • Price
  • AFYA $15.44
  • ARQT $15.76
  • Analyst Decision
  • AFYA Sell
  • ARQT Strong Buy
  • Analyst Count
  • AFYA 5
  • ARQT 6
  • Target Price
  • AFYA $17.60
  • ARQT $18.80
  • AVG Volume (30 Days)
  • AFYA 105.6K
  • ARQT 2.0M
  • Earning Date
  • AFYA 08-15-2025
  • ARQT 08-13-2025
  • Dividend Yield
  • AFYA 1.57%
  • ARQT N/A
  • EPS Growth
  • AFYA 41.32
  • ARQT N/A
  • EPS
  • AFYA 1.31
  • ARQT N/A
  • Revenue
  • AFYA $599,363,389.00
  • ARQT $212,819,000.00
  • Revenue This Year
  • AFYA $15.52
  • ARQT $61.01
  • Revenue Next Year
  • AFYA $8.72
  • ARQT $37.95
  • P/E Ratio
  • AFYA $11.95
  • ARQT N/A
  • Revenue Growth
  • AFYA 15.70
  • ARQT 100.03
  • 52 Week Low
  • AFYA $14.52
  • ARQT $7.86
  • 52 Week High
  • AFYA $19.90
  • ARQT $17.75
  • Technical
  • Relative Strength Index (RSI)
  • AFYA 24.37
  • ARQT 60.23
  • Support Level
  • AFYA $17.33
  • ARQT $13.06
  • Resistance Level
  • AFYA $18.16
  • ARQT $15.36
  • Average True Range (ATR)
  • AFYA 0.43
  • ARQT 0.66
  • MACD
  • AFYA -0.21
  • ARQT 0.12
  • Stochastic Oscillator
  • AFYA 3.67
  • ARQT 82.57

About AFYA Afya Limited

Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergrad provides educational services through undergraduate courses related to medical school, undergraduate health science and other ex-health undergraduate programs, Continuing Education provides medical education, specialization and graduate courses in medicine, delivered through digital and in-person content; and Medical practice solution provides clinical decision, clinical management and doctor-patient relationships for physicians and provide access, demand and efficiency for the healthcare players.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

Share on Social Networks: